Skip to main content
. 2021 Sep 30;4(4):196–207. doi: 10.36401/JIPO-21-14

Figure 3.

Figure 3

Forrest plots for meta-analysis of prevalence of medication-related osteonecrosis of the jaw in patients administered (a) concurrent antiresorptive and anti-angiogenic drugs, (b) antiangiogenic drugs only, and (c) antiresorptive drugs only. Red square: weighted prevalence estimate of individual study; horizontal black line: 95% CI of individual study result; diamond: pooled prevalence estimate.